Kardigan, Inc. Common Stock Total Liabilities
Kardigan, Inc. Common Stock total liabilities. Based on the latest financial reports, Kardigan, Inc. Common Stock (KARD) has total liabilities worth $106.26 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Kardigan, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Kardigan, Inc. Common Stock (2024–2025)
Total liabilities of Kardigan, Inc. Common Stock from 2024 to 2025. This chart illustrates how Kardigan, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Check Kardigan, Inc. Common Stock liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Kardigan, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Kardigan, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Suzhou Veichi Electric Co. Ltd. A
SHG:688698
|
China | CN¥1.29 Billion |
|
Aygaz AS
IS:AYGAZ
|
Turkey | TL12.66 Billion |
|
Teladoc Inc
NYSE:TDOC
|
USA | $1.49 Billion |
|
V-Guard Industries Limited
NSE:VGUARD
|
India | Rs-23.73 Billion |
|
Adient PLC
NYSE:ADNT
|
USA | $6.80 Billion |
|
Anhui Hengyuan Coal Industry and Electricity Power Co Ltd
SHG:600971
|
China | CN¥13.36 Billion |
|
Liquidity Services Inc
NASDAQ:LQDT
|
USA | $184.24 Million |
|
Shanghai Environment Group Co Ltd
SHG:601200
|
China | CN¥17.10 Billion |
Liability Composition Analysis (2024–2025)
This chart breaks down Kardigan, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see KARD total asset value.
Liquidity & Leverage Metrics
Kardigan, Inc. Common Stock Total Liabilities Ratios Explained
Kardigan, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kardigan, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kardigan, Inc. Common Stock (2024–2025)
The table below shows the annual total liabilities of Kardigan, Inc. Common Stock from 2024 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $641.28 Million | +337.08% |
| 2024-12-31 | $146.72 Million | -- |
About Kardigan, Inc. Common Stock
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI… Read more